Obed Aiman, Stern Steffen, Jarrad Anwar, Lorf Thomas
Aiman Obed, Anwar Jarrad, Hepatobiliary and Liver Transplant Unit, Jordan Hospital, Amman 11152, Jordan.
World J Gastroenterol. 2015 Apr 14;21(14):4423-6. doi: 10.3748/wjg.v21.i14.4423.
Alcoholic liver disease (ALD) is the second most common diagnosis among patients undergoing liver transplantation (LT). The recovery results of patients transplanted for ALD are often at least as good as those of patients transplanted for other diagnoses and better than those suffering from hepatitis C virus, cryptogenic cirrhosis, or hepatocellular carcinoma. In the case of medically non-responding patients with severe acute alcoholic hepatitis or acute-on chronic liver failure, the refusal of LT is often based on the lack of the required alcohol abstinence period of six months. The obligatory abidance of a period of abstinence as a transplant eligibility requirement for medically non-responding patients seems unfair and inhumane, since the majority of these patients will not survive the six-month abstinence period. Data from various studies have challenged the 6-mo rule, while excellent survival results of LT have been observed in selected patients with severe alcoholic hepatitis not responding to medical therapy. Patients with severe advanced ALD should have legal access to LT. The mere lack of pre-LT abstinence should not be an obstacle for being listed.
酒精性肝病(ALD)是肝移植(LT)患者中第二常见的诊断疾病。因ALD接受移植的患者的恢复结果通常至少与因其他诊断接受移植的患者一样好,且优于丙型肝炎病毒、隐源性肝硬化或肝细胞癌患者。对于药物治疗无反应的严重急性酒精性肝炎或慢加急性肝衰竭患者,拒绝进行肝移植往往是基于缺乏所需的六个月戒酒期。对于药物治疗无反应的患者,将强制戒酒期作为移植资格要求似乎不公平且不人道,因为这些患者中的大多数无法度过六个月的戒酒期。来自各种研究的数据对六个月规则提出了挑战,同时在选定的对药物治疗无反应的严重酒精性肝炎患者中观察到了良好的肝移植生存结果。严重晚期ALD患者应有合法途径接受肝移植。仅仅缺乏肝移植前的戒酒不应成为列入移植名单的障碍。